Quick Answer
Neuraxis, INC reported Diluted EPS of $0.95 per share (loss) for fiscal year 2025.
Neuraxis, INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.95 | +22.1% |
| 2024 | -$1.22 | +72.9% |
| 2023 | -$4.50 | -62.5% |
| 2022 | -$2.77 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.24 | +4.0% | -9.1% |
| June 30, 2025 | -$0.22 | +47.6% | +33.3% |
| March 31, 2025 | -$0.33 | -3.1% | -32.0% |
| September 30, 2024 | -$0.25 | +89.5% | +40.5% |
| June 30, 2024 | -$0.42 | +65.3% | -31.2% |
| March 31, 2024 | -$0.32 | +72.9% | +86.6% |
| September 30, 2023 | -$2.38 | -108.8% | -96.7% |
| June 30, 2023 | -$1.21 | -39.1% | -2.5% |
- Neuraxis, INC showed an increase of +22.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Neuraxis, INC’s diluted eps has grown by 65.7% (from $2.77 per share (loss) to $0.95 per share (loss)).
- The most recent figure is from Neuraxis, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: